Drupal-Bibcite31<style face="normal" font="default" size="100%">Risk of hyperkalemia from renin-angiotensin-aldosterone system inhibitors and factors associated with treatment discontinuities in a real-world population</style><style face="normal" font="default" size="100%">Risk of hyperkalemia from renin-angiotensin-aldosterone system inhibitors and factors associated with treatment discontinuities in a real-world population</style>